Efficacy of Ibrexafungerp (formerly SCY-078) in a Murine Therapeutic Model of Pneumocystis Pneumonia
Stephen A. Barat, PhDASM Microbe 2019
June 2019
Efficacy of Ibrexafungerp (IBX, formerly SCY-078) in the Treatment of Candida auris Cutaneous Infection in a Guinea Pig Model
M. Ghannoum, L. Long, C. Hager, K. Borroto-Esoda, S. Barat, and D. AnguloASM Microbe 2019
June 2019
Efficacy of Ibrexafungerp (formerly SCY-078) Against Pneumocystis Pneumonia in a Murine Therapeutic Model
Stephen A. Barat, Katyna Borroto-Esoda, David A. Angulo, Alan Ashbaugh, Melanie CushionASM Microbe 2019
June 2019
Preclinical Safety Evaluation of the Novel Antifungal Ibrexafungerp (formerly SCY-078) Supports Long-Term Dosing
Christina M. Carruthers, Stephen A. Barat, and David AnguloASM Microbe 2019
June 2019
Penetration of Ibrexafungerp (formerly SCY-078) versus Micafungin at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model
Annie Lee, Brendan Prideaux, Min Hee Lee, Matthew Zimmerman, Padmaja Paderua, Stephen A. Barat, David Angulo, David S. Perlin, Yanan ZhaoASM Microbe 2019
June 2019
Activity of a novel 1,3-beta-D-glucan inhibitor, Ibrexafungerp (formerly SCY-078), against Candida glabrata
M. Ghannoum, L. Long, C. Hager, R. Wilson, K. Borroto-Esoda, S. Barat, and D. AnguloASM Microbe 2019
June 2019
Efficacy of Oral Ibrexafungerp (IBX, Formerly SCY-078) in the Treatment of Candida auris Infection in a Murine Disseminated Model
M. Ghannoum, L. Long, C. Hager, K. Borroto-Esoda, S. Barat, and D. AnguloASM Microbe 2019
June 2019
Interim Analysis of a Phase 3 Open-label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (formerly SCY-078) in Patients with Refractory or Intolerant Fungal Diseases (FURI)
OA Cornely, L Ostrosky-Zeichner, R Miller, A Spec, GR Thompson, TJ Walsh, R Rautemaa-Richardson, R Krause, KM Mullane, PG Pappas, CGMorse, JW Sanders, G Weiss, O Witzke, J Vazquez, MH Miceli, TF Patterson, M Hoenigl, BD Alexander, DA Angulo
ASM Microbe 2019
June 2019
Ibrexafungerp, a Novel Oral Antifungal, Demonstrates No Reproductive or Developmental Harm in Preclinical Models
C.M. Carruthers, S. Barat, D. Angulo, P. Thomas, E. Lewis, R. SobelACOG 2019
May 2019